Evaluate the relative efficiency of a targeted clinical trial design to an untargeted design under the issue of cost (Q4606473)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Evaluate the relative efficiency of a targeted clinical trial design to an untargeted design under the issue of cost |
scientific article; zbMATH DE number 6848007
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Evaluate the relative efficiency of a targeted clinical trial design to an untargeted design under the issue of cost |
scientific article; zbMATH DE number 6848007 |
Statements
Evaluate the relative efficiency of a targeted clinical trial design to an untargeted design under the issue of cost (English)
0 references
7 March 2018
0 references
clinical trials
0 references
efficacy
0 references
heterogeneity
0 references
sample size determination
0 references
screen tool
0 references
targeted design
0 references
0.6700994968414307
0 references
0.6550855040550232
0 references
0.6458737254142761
0 references
0.6442127227783203
0 references
